Search

Your search keyword '"Longtin, Yves"' showing total 335 results

Search Constraints

Start Over You searched for: Author "Longtin, Yves" Remove constraint Author: "Longtin, Yves"
335 results on '"Longtin, Yves"'

Search Results

1. WHO global research priorities for antimicrobial resistance in human health

2. Characterization of Healthcare Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada,2015-2019

3. Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay

4. Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement

5. Seroprevalence du SRAS-CoV-2 chez les travailleurs de la sante de 10 hopitaux du Quebec, au Canada : etude transversale

6. WHO global research priorities for antimicrobial resistance in human health

7. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study

10. Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008-2015

11. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices

12. 1351. Predictors of Loss of Infectivity Among Healthcare Workers with Primary and Recurrent SARS-CoV-2 infection: An Observational Cohort Study

14. Cohort profile: A multicenter evaluation of clinical decision rules applied to emergency department triage of patients presenting with acute respiratory infection or infectious diarrhea

17. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial

19. Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent Coronavirus Disease 2019 (COVID-19): A Prospective Observational Cohort Study

21. A Burkholderia stabilis outbreak associated with the use of ultrasound gel in multiple healthcare centres in Montréal, Canada, May–October 2021

22. Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance Program

23. Éclosion de Burkholderia stabilis associée à l’utilisation d’un gel à ultrasons dans plusieurs centres de soins de santé à Montréal, Canada, de mai à octobre 2021

24. Utilisation du nirmatrelvir/ritonavir chez les adultes admis à l’hôpital en raison de la COVID-19 pendant la phase Omicron de la pandémie de COVID-19, Programme canadien de surveillance des infections nosocomiales

25. Post-pandemic evaluation of the eco-efficiency of personal protective equipment against COVID-19 in emergency departments: a mixed method study protocol (Preprint)

27. Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study.

28. Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.

29. Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality

30. Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022

37. The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015)

38. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

44. Risk and protective factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers: A test-negative case–control study in Québec, Canada

46. Author response for 'The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers'

47. The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers

48. Immunogenicity of Pfizer-BioNTech COVID-19 mRNA Primary Vaccination Series in Recovered Individuals Depends on Symptoms at Initial Infection

Catalog

Books, media, physical & digital resources